AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyNot reportedTrial registry
Investigation of Skin Tumor Causes in Human Patients with Tuberous Sclerosis
A study is planned to explore the genetic causes of skin tumors in 400 patients diagnosed with tuberous sclerosis, aiming to identify specific tumor cells through genetic analysis.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
Understanding the genetic basis of skin tumors in tuberous sclerosis patients could lead to better understanding of tumor development in this population, potentially guiding future research and interventions.
What this does not prove
The study has not published results, and details like planned enrollment and endpoints are unreported, leaving efficacy and outcomes unknown.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- 400 · basis not reported
- Randomised
- Not reported
- Controlled
- Not applicable
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Trial registrationStudy of Skin Tumors in Tuberous Sclerosis ↗
Supporting passages (6)
subjectsPatients will be those already diagnosed with TSC (definite or possible) based on clinical criteria and/or genetic testing, and ranging in age from 18 to 90 years old.
sample sizePatients will not be preselected for skin lesions, but about 80% of patients with TSC are expected to have skin lesions.\n\nEXCLUSION CRITERIA:\n\nInability to give informed consent.\n\nTendency to keloid formation.\n\nAllergy to anesthetics.\n\nBleeding abnormality.",
controlledThe cutaneous features of tuberous sclerosis: a population study.
primary endpoint"measure": "1.Identify the tumor cells in cutaneous and mucosal tumors in patients with TSC through LOH studies on microdissected cell populations",
findingsThis study will investigate what causes skin tumors to develop in patients with this disease.
limitationsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.